Your browser doesn't support javascript.
loading
Research progress of chimeric antigen receptor T cells in the treatment of primary liver cancer / 基础医学与临床
Basic & Clinical Medicine ; (12): 1016-1019, 2018.
Artigo em Chinês | WPRIM | ID: wpr-694027
ABSTRACT
CAR-T technology as a kind of immunotherapy, from the earliest generation of the first to the current fourth generation, its cytotoxic, anti-tumor immune effect greatly enhanced, but also challenged by safety issues.It shows a certain advantage in the therapy of Hepatocellular carcinoma. It indicates that the era of precise individual-ized liver cancer treatment, immune therapy, especially CAR-T technology combined with surgery, radiotherapy and chemotherapy, local treatment and other comprehensive treatment will play a more powerful role.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Basic & Clinical Medicine Ano de publicação: 2018 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Basic & Clinical Medicine Ano de publicação: 2018 Tipo de documento: Artigo